Median Technologies

Join us at ESMO 2018 in Munich, Germany.  Visit booth B1 – 157 to learn more about the Median advantage in oncology clinical trials.  Abstract: Reproducibility of the mRECIST criteria for the assessment of HCC treated by anti- VEGFR therapy: Impact of readers’ expertise

Join us at OCT SoCal in La Jolla, CA in September.

Join us in Seville at BioSpain in September.

Join us in Boston at the Disruptive Innovations to Advance Clinical Trials conference.